Arno Therapeutics, Inc. HomeAbout UsPipelineInvestor RelationsContact Us
Creating the next generation of cancer treatments
Investor & Media
Press ReleasesIn the NewsPublicationsEvents & PresentationsAnalyst Coverage
Stock InformationSEC FilingsGovernanceTransfer Agent

We are committed to creating sustainable long-term value for our shareholders by developing potential best- or first-in-class targeted agents for the treatment of cancer. We are pursuing this mission along clinical and regulatory pathways that are efficient and well-defined.

Arno Therapeutics, Inc.
200 Route 31 North
Suite 104
Flemington, NJ 08822

(862) 703-7170 Main
(908) 237-0071 Fax